Strategic partner

Olivier Lavergne has founded in 2017 Chem4LS, a consultancy dedicated to the application of synthetic organic chemistry and medicinal chemistry in life sciences and biotech projects. Holding an engineering degree from CPE-Lyon and a PhD in organic chemistry from Wayne State University (Detroit, Michigan), Olivier brings in 30 years of experience in pharmaceutical research acquired in France and Spain, during which he led many projects mainly in oncology, CNS and endocrinology. He is a co-inventer and co-author of several dozens of patents and research articles. Since July 2020 Chem4LS is partnering with Oxeltis to offer a broader medicinal chemistry experience to its clients and maximize the success of their projects.